CCG-1423 25mg 25mg | Purity Not Available
Adooq Bioscience
CCG-1423 is a specific inhibitor of Rho pathway-mediated signaling and activation of serum response factor (SRF) transcription.
More Information Supplier PageSearch Results
CCG-1423 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
CCG-1423 is a specific inhibitor of Rho pathway-mediated signaling and activation of serum response factor (SRF) transcription.
More Information Supplier PageCCG-1423 100mg 100mg | Purity Not Available
Adooq Bioscience
CCG-1423 is a specific inhibitor of Rho pathway-mediated signaling and activation of serum response factor (SRF) transcription.
More Information Supplier PageNetupitant 5mg 5mg | Purity Not Available
Adooq Bioscience
Netupitant is a selective neurokinin 1 (NK1) receptor. It competitively binds to and blocks the activity of the human substance P/NK1 receptors in the central nervous system (CNS), thereby inhibiting NK1-receptor binding of the endogenous tachykinin neuropeptide substance P (SP), which may result in the prevention of chemotherapy-induced nausea and vomiting (CINV).
More Information Supplier PageNetupitant 25mg 25mg | Purity Not Available
Adooq Bioscience
Netupitant is a selective neurokinin 1 (NK1) receptor. It competitively binds to and blocks the activity of the human substance P/NK1 receptors in the central nervous system (CNS), thereby inhibiting NK1-receptor binding of the endogenous tachykinin neuropeptide substance P (SP), which may result in the prevention of chemotherapy-induced nausea and vomiting (CINV).
More Information Supplier PageNetupitant 10mg 10mg | Purity Not Available
Adooq Bioscience
Netupitant is a selective neurokinin 1 (NK1) receptor. It competitively binds to and blocks the activity of the human substance P/NK1 receptors in the central nervous system (CNS), thereby inhibiting NK1-receptor binding of the endogenous tachykinin neuropeptide substance P (SP), which may result in the prevention of chemotherapy-induced nausea and vomiting (CINV).
More Information Supplier PageSBE 13 HCl 50mg 50mg | Purity Not Available
Adooq Bioscience
SBE 13 HCl is a selective inhibitor of PLK1 (IC50 values are 200 pM, 875 nM and 66 ??M for PLK1, PLK3 and PLK2 respectively).
More Information Supplier PageSBE 13 HCl 25mg 25mg | Purity Not Available
Adooq Bioscience
SBE 13 HCl is a selective inhibitor of PLK1 (IC50 values are 200 pM, 875 nM and 66 ??M for PLK1, PLK3 and PLK2 respectively).
More Information Supplier PageACTB-1003 10mg 10mg | Purity Not Available
Adooq Bioscience
ACTB-1003 is an oral kinase inhibitor targeting cancer mutations (FGFR inhibition), angiogenesis (inhibition of VEGFR2 and Tie-2) and induces apoptosis (targeting RSK and p70S6K, downstream of PI3 kinase).
More Information Supplier PageACTB-1003 5mg 5mg | Purity Not Available
Adooq Bioscience
ACTB-1003 is an oral kinase inhibitor targeting cancer mutations (FGFR inhibition), angiogenesis (inhibition of VEGFR2 and Tie-2) and induces apoptosis (targeting RSK and p70S6K, downstream of PI3 kinase).
More Information Supplier Page